利益相反の開示と管理 - AMED

1 1 2019 3 29 < > AMED 2 icmje 3 Conflicts of Interest: COI * COI COI financial COI COI non-financial COI COI icmje COI COI disclosure form COI 4 Conflicts of Interest.

2 COI 2006 3 2008 3 Conflict of Interest COI 2011 2 COI 2015 4 2017 2 2018 6 2014 2 2015 3 2017 3 COI 2018 4 COI COI COI financial COI COI 5 COI COI COI The New England journal of Medicine The Lancet international Committee of medical journal Editors icmje r ecommendations recommendations COI COI disclosure form 6 COI

3 COI COI COI COI COI 6 COI COI [1] COI embarrassed [2, 3] COI COI COI [4]

4 7 COI COI COI [2, 4, 5] 1 5 [5] COI [2, 5] COI [6] COI Acknowledgements [1, 5] COI [1, 2, 5] COI icmje icmje r ecommendations The New England journal of Medicine The Lancet JAMA B.

5 Author Responsibilities - Conflicts of Interest COI COI disclosure form 3 8 1 The New England journal of Medicine 2 non-financial COI 3 1 COI 2 [7] MR medical Representative MR icmje COI 3 9 COI icmje COI COI disclosure form icmje Web

6 COI COI [4] The New England journal of Medicine COI COI disclosure form COI COI [1] 3 [1] JAMA 10 1 Contributors trial design protocol data collection management analysis interpretation preparation review approval principal

7 Investigator 2 Role of funding sources funder 11 3 Acknowledgements writer former employee AMED AMED 12 [1] The journal of American medical Association (JAMA) [2] Nature [3] The European Molecular Biology Organization (EMBO) journal [4] The Lancet [5] Cell [6] Science [7] The New England journal of Medicine